Adtalem Global Education beats Q1 revenue estimates

Reuters
Oct 31, 2025
Adtalem Global Education beats Q1 revenue estimates

Overview

  • Adtalem fiscal Q1 revenue grows 10.8% yr/yr, beating analyst expectations

  • Adjusted EPS for fiscal Q1 grows 35.7% yr/yr, reflecting strong operational performance

  • Company repurchased $8 mln of shares, increased credit facility by $100 mln

Outlook

  • Adtalem maintains fiscal year 2026 revenue guidance at $1,900 mln to $1,940 mln

  • Company expects fiscal year 2026 adjusted EPS between $7.60 and $7.90

  • Adtalem plans Investor Day on Feb. 24, 2026

Result Drivers

  • ENROLLMENT GROWTH - Total student enrollment increased 8.0% YoY, driven by growth at Chamberlain, Walden, and Medical & Veterinary segments

  • WALDEN UNIVERSITY - Achieved highest total enrollment in history, up 13.6% YoY, contributing significantly to revenue growth

  • AI INTEGRATION - Partnership with Google Cloud to develop AI credentials program for healthcare students, enhancing educational offerings

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$462.30 mln

$452.30 mln (4 Analysts)

Q1 Net Income

$61.80 mln

Q1 Adjusted EBITDA

Beat

$112 mln

$108.99 mln (3 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous educational service providers peer group is "buy."

  • Wall Street's median 12-month price target for Adtalem Global Education Inc is $171.00, about 17.5% above its October 29 closing price of $141.04

Press Release: ID:nBw65Whbga

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10